The panel discusses how to educate patients and caregivers on infections risks when receiving an anti-BCMA bispecific antibody.
Navigating AE Management for Cellular Therapy Across Hematologic Cancers
A panel of clinical pharmacists discussed strategies for mitigating toxicities across different multiple myeloma, lymphoma, and leukemia populations.